<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02541929</url>
  </required_header>
  <id_info>
    <org_study_id>HS-14-00864</org_study_id>
    <nct_id>NCT02541929</nct_id>
  </id_info>
  <brief_title>Fish Oil Brain Delivery Study</brief_title>
  <official_title>Fish Oil Brain Delivery Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alzheimer's Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Docosahexaenoic acid (DHA) is an essential omega-3 fish oil. DHA is critical to the structure
      and function of brain cells.

      DHA fish oil has been shown to be beneficial in cognition in several animal studies; however,
      this effect in human studies is not clear. It is not known how much dietary fish oil can get
      into the human brain. Thus, exploring fish oil delivery in human brains is critical for
      designing appropriate interventions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  The investigators goal is to study how different people deliver DHA to the brain.

        -  The study will only require two visits six months apart and involve taking DHA during
           these 6 months.

        -  Participants will receive DHA supplements for the study duration and a compensation for
           each study visit.

        -  Blood and cerebrospinal fluid levels of DHA will be measured before and after taking
           DHA.

        -  Brain imaging by MRI will be obtained at baseline and at conclusion of study

        -  This study will help us learn how much of the ingested DHA goes to the brain.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">October 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in DHA levels in the CSF following dietary DHA supplementation</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain MRI</measure>
    <time_frame>6 months and 1 year</time_frame>
    <description>Structural and functional connectivity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Brain Health</condition>
  <arm_group>
    <arm_group_label>DHA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DHA (2grams/day) for 26 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo (4 capsules per day) for 26 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Docosahexaenoic acid</intervention_name>
    <arm_group_label>DHA</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages 40 and above

          -  at risk of Alzheimer's disease such as family history of dementia

          -  women have to be post menopausal

        Exclusion Criteria:

          -  current intake of fish oil or omega-3 supplements

          -  history of prior heart attack, coronary bypass or percutaneous luminal angioplasty or
             strokes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hussein Yassine, MD</last_name>
    <phone>323-442-1909</phone>
  </overall_contact>
  <location>
    <facility>
      <name>USC Keck School of Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hussein Yassine</last_name>
      <phone>323-489-4896</phone>
      <email>fishoilforbrain@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.yassinelab.com</url>
    <description>Yassine Lab Website</description>
  </link>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Hussein Yassine</investigator_full_name>
    <investigator_title>Dr. Hussein N. Yassine, MD</investigator_title>
  </responsible_party>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Docosahexaenoic acid</keyword>
  <keyword>brain health</keyword>
  <keyword>memory</keyword>
  <keyword>fish oil</keyword>
  <keyword>cognition</keyword>
  <keyword>DHA</keyword>
  <keyword>omega 3 fatty acid</keyword>
  <keyword>brain</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

